New ZLG Document on Transport Verification Published

Recommendation
Wednesday, 30 April 2025 9 .00 - 17.30 h
How to Audit Logistics Service Providers
The German Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices (Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten, ZLG) has published a newly prepared document entitled "Inspektion der Eignung von Transportprozessen" (Inspection of the Suitability of Transport Processes). The PDF file with the identifier AiM 07123201 is publicly available for download in German language on the ZLG Homepage (Quality Manual, chapter 7).
The document, which is applicable to GMP and GDP areas, is primarily aimed at the personnel of the competent authorities. It is a so-called Aide mémoire (AiM), a catalogue of standards, questions and recommendations, which serves to harmonise the preparation, execution and follow-up of an inspection.
The transport of medicinal products and veterinary medicinal products as well as active pharmaceutical ingredients (APIs) are considered. Therefore, the contents are not only of interest to inspectors, but also to pharmaceutical manufacturers and wholesalers.
Content of the new Document
The twelve-page paper starts with a description of the purpose and an overview with definitions, abbreviations and references to core documents.
The main chapters deal with the following aspects:
- Procedure for transport verification: The procedure for transport verification, including the preceding steps, is described using an exemplary flow chart. The definition of the transport process and the controls as well as the topics of risk analysis, assessment and control are addressed.
- Transport verification: The relevant points to be verified on the basis of the documentation are listed.
- Transport verification vs. validation: The difference between the two terms is pointed out, and it is highlighted that due to the variability of transport processes, transport validation is often only achievable for sub-processes.
- Ensuring the quality of medicines, veterinary medicines and APIs throughout the supply chain.
Additional literature is referred to at the end of the document.
Related GMP News
11.03.2025USP Publishes Summary of Comments on Chapter <1079.2> Regarding Mean Kinetic Temperature (MKT)
11.03.2025EMA: No further Extension of GDP Certificates in 2025
11.03.2025Aide-Mémoires and Checklists in GDP Audits - Benefits and Risks
13.02.2025MHRA updates Guidance on Sourcing Medicines for the UK Market
13.02.2025First GDP Non-Compliance Report of 2025: Data Integrity Issues at Hungarian Wholesaler